# clm_B2B75C38DC99

subject: Novo Nordisk (/record/novo-nordisk.md)  
predicate: operating_income  
value: 52,483,000,000 DKK  
valid_from: 2019-12-31  
valid_to: 2020-12-31  
published: 2022-02-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_D272A9AE2D76  
last_updated: 2026-11-08  
cite: AsOf. "Novo Nordisk operating income: 52,483,000,000 DKK", as of 2019-12-31 (until 2020-12-31). Claim clm_B2B75C38DC99, https://asof.is/claim/clm_B2B75C38DC99, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2021, filed 2022-02-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm (primary, SEC EDGAR 20-F FY2021, published 2022-02-02)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.